Login / Signup

Combination therapy for treatment of Pseudomonas aeruginosa bloodstream infections.

Sarah Tschudin-SutterNicole FosseReno FreiAndreas F Widmer
Published in: PloS one (2018)
Combination therapy (i.e. betalactam-aminoglycoside or betalactam-quinolone combinations) may improve survival of P. aeruginosa BSI, independent of potential confounders such as age, neutropenia, PITT bacteremia score, and inadequate empirical treatment.
Keyphrases
  • combination therapy
  • pseudomonas aeruginosa
  • cystic fibrosis
  • acinetobacter baumannii
  • escherichia coli
  • staphylococcus aureus
  • drug resistant
  • climate change
  • biofilm formation
  • multidrug resistant
  • smoking cessation